These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8447805)

  • 1. Treatment efficacy of intramuscular promethazine for space motion sickness.
    Davis JR; Jennings RT; Beck BG; Bagian JP
    Aviat Space Environ Med; 1993 Mar; 64(3 Pt 1):230-3. PubMed ID: 8447805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of treatment strategies for Space Motion Sickness.
    Davis JR; Jennings RT; Beck BG
    Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment strategies for Space Motion Sickness.
    Davis JR; Jennings RT; Beck BG
    Acta Astronaut; 1993 Aug; 29(8):587-91. PubMed ID: 11541638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Space motion sickness during 24 flights of the space shuttle.
    Davis JR; Vanderploeg JM; Santy PA; Jennings RT; Stewart DF
    Aviat Space Environ Med; 1988 Dec; 59(12):1185-9. PubMed ID: 3240221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe motion sickness with antimotion sickness drug injections.
    Graybiel A; Lackner JR
    Aviat Space Environ Med; 1987 Aug; 58(8):773-6. PubMed ID: 3632537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing space motion sickness.
    Jennings RT
    J Vestib Res; 1998; 8(1):67-70. PubMed ID: 9416592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms.
    Cowings PS; Toscano WB
    J Clin Pharmacol; 2000 Oct; 40(10):1154-65. PubMed ID: 11028255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of aerobic fitness and space motion sickness during the shuttle program.
    Jennings RT; Davis JR; Santy PA
    Aviat Space Environ Med; 1988 May; 59(5):448-51. PubMed ID: 3390102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of promethazine and its failure to produce the expected incidence of sedation during space flight.
    Bagian JP; Ward DF
    J Clin Pharmacol; 1994 Jun; 34(6):649-51. PubMed ID: 9766972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical use by U.S. astronauts on space shuttle missions.
    Putcha L; Berens KL; Marshburn TH; Ortega HJ; Billica RD
    Aviat Space Environ Med; 1999 Jul; 70(7):705-8. PubMed ID: 10417009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of motion sickness in parabolic flight with buccal scopolamine.
    Norfleet WT; Degioanni JJ; Calkins DS; Reschke MF; Bungo MW; Kutyna FA; Homick JL
    Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
    Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
    Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of space sickness in shuttle-orbiter missions.
    Graybiel A
    Aviat Space Environ Med; 1979 Feb; 50(2):171-6. PubMed ID: 36067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side effects of antimotion sickness drugs.
    Wood CD; Manno JE; Manno BR; Redetzki HM; Wood M; Vekovius WA
    Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promethazine as a motion sickness treatment: impact on human performance and mood states.
    Cowings PS; Toscano WB; DeRoshia C; Miller NE
    Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of motion sickness and antimotion sickness drugs on gastric function.
    Stewart JJ; Wood MJ; Wood CD; Mims ME
    J Clin Pharmacol; 1994 Jun; 34(6):635-43. PubMed ID: 8083395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A; Knepton J; Shaw J
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motion sickness in cats: a symptom rating scale used in laboratory and flight tests.
    Suri KB; Crampton GH; Daunton NG
    Aviat Space Environ Med; 1979 Jun; 50(6):614-8. PubMed ID: 475712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First intramuscular administration in the U.S. Space Program.
    Bagian JP
    J Clin Pharmacol; 1991 Oct; 31(10):920. PubMed ID: 1761721
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of simulated weightlessness on the intramuscular and oral pharmacokinetics of promethazine in 12 human volunteers.
    Gandia P; Saivin S; Le-Traon AP; Guell A; Houin G
    J Clin Pharmacol; 2006 Sep; 46(9):1008-16. PubMed ID: 16920895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.